Abstract
The introduction of ultrasound screening combined with the increasingly elderly population means that the number of small abdominal aortic aneurysms (AAAs) detected is expected to increase over the next decade. At present open or endovascular surgery are the only treatment options for AAA. In this mini-review we discuss the rationale and ongoing attempts to develop non-surgical therapies for AAA.
Keywords: Abdominal aortic aneurysm, medication
Current Vascular Pharmacology
Title: Developments in Non-Surgical Therapies for Abdominal Aortic Aneurysm
Volume: 7 Issue: 2
Author(s): Jonathan Golledge, Ronald L. Dalman and Paul E. Norman
Affiliation:
Keywords: Abdominal aortic aneurysm, medication
Abstract: The introduction of ultrasound screening combined with the increasingly elderly population means that the number of small abdominal aortic aneurysms (AAAs) detected is expected to increase over the next decade. At present open or endovascular surgery are the only treatment options for AAA. In this mini-review we discuss the rationale and ongoing attempts to develop non-surgical therapies for AAA.
Export Options
About this article
Cite this article as:
Golledge Jonathan, Dalman L. Ronald and Norman E. Paul, Developments in Non-Surgical Therapies for Abdominal Aortic Aneurysm, Current Vascular Pharmacology 2009; 7 (2) . https://dx.doi.org/10.2174/157016109787455608
DOI https://dx.doi.org/10.2174/157016109787455608 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review of QSAR studies to Discover New Drug-like Compounds Actives Against Leishmaniasis and Trypanosomiasis
Current Topics in Medicinal Chemistry A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options
Current Medicinal Chemistry Applications of Nucleic Acid Drugs for Organ Transplantation
Current Topics in Medicinal Chemistry Infection, Infectious Agents and Vascular Disease
Reviews on Recent Clinical Trials Atypical Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: A Systematic Review
Current Pediatric Reviews Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry Screening, Evaluation, and Early Management of Acute Aortic Dissection in the ED
Current Cardiology Reviews The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews The Imaging of Apoptosis with the Radiolabelled Annexin A5: A New Tool in Translational Research
Current Clinical Pharmacology Meta-Analysis of the Effectiveness and Safety of Prophylactic Use of Nimodipine in Patients with an Aneurysmal Subarachnoid Haemorrhage
CNS & Neurological Disorders - Drug Targets Why Multiples of 21? Why does Selenoprotein P Contain Multiple Selenocysteine Residues?
Current Nutraceuticals Endothelial Remodelling and Intracellular Calcium Machinery
Current Molecular Medicine Behçets Disease as an Autoinflammatory Disorder
Current Drug Targets - Inflammation & Allergy Genetic Polymorphisms of Type-1 and Type-2 Inflammatory Cytokines in Ischaemic Stroke
Vascular Disease Prevention (Discontinued) Vascular Modeling from Volumetric Diagnostic Data: A Review
Current Medical Imaging Diverse Functions and Mechanisms of Pericytes in Ischemic Stroke
Current Neuropharmacology Recent Progress in Cerebrovascular Gene Therapy
Current Neurovascular Research Effects of Erythropoietin on Brain Function
Current Pharmaceutical Biotechnology Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design Near Infrared Optical Technologies to Illuminate the Status of the Neonatal Brain
Current Pediatric Reviews